The Tolerability of Saracatinib in Subjects With Lymphangioleiomyomatosis (LAM) (SLAM-1)
Clinical trial NCT02116712 · COMPLETED
Trial details
- NCT number
- NCT02116712
- Sponsor
- Tony Eissa
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-08-01
- Primary completion
- 2015-06-01
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.